
    
      PROTOCOL OUTLINE:

      Patients receive cyclophosphamide IV on days 1-4 and filgrastim (G-CSF) beginning on day 10
      and continuing until blood counts recover.

      Patients are followed monthly for 6 months, and then every 3 months thereafter.
    
  